A Los Angeles jury ordered Johnson & Johnson to pay $40 million to two women on December 13, 2025. The women claimed the ...

After multiple failed attempts by Johnson & Johnson to move its talc litigation into bankruptcy, ovarian cancer claims are once again advancing in courts across the country. LOS ANGELES, Dec. 30, 2025 ...

Shelby is an editor with an affinity for covering home improvement and repair, design and real estate trends. She also specializes in content strategy and entrepreneur coaching for small businesses, ...

A jury in Minnesota has awarded $65.5 million to a mother of three who said talcum products made by Johnson & Johnson ...

Beauty products are often filled with ingredients that most of us probably don’t recognize ― and can’t even pronounce. While that’s not inherently a bad thing, there is a rising emphasis on clean ...

Johnson & Johnson is facing a new proposed class action seeking damages and medical monitoring on behalf of women who have been diagnosed with cancer, or might develop it in the future, allegedly as a ...

CHICAGO -- Johnson & Johnson is trying once again to use the bankruptcy courts to settle tens of thousands of cases that claim its talc products cause cancer. The pharmaceutical company is now willing ...

New research published this week lends credence to the more than 50,000 lawsuits against Johnson & Johnson that allege its talc-based baby powder caused ovarian cancer. The analysis, released ...

Oct 15 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab must pay $15 million to a Connecticut man who alleges that he developed mesothelioma, a rare form of cancer, as a result of using the ...

Johnson & Johnson is willing to pay almost $9 billion to settle thousands of lawsuits alleging that its talcum powder caused cancers, the company announced Apr. 4. The proposal is the latest chapter ...

Matt Fuchs lives in Maryland and writes about health, science, and technology. Matt Fuchs lives in Maryland and writes about health, science, and technology. Updates on Trump, Gaza, COVID-19, and more ...